Trial Profile
A Double Blind, Randomized, Two Period Crossover Study To Determine The Effect of Multiple Doses of 120 MG Modified Release Formulation of YM150 on the Steady State Pharmacokinetics of Digoxin in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Jan 2012
Price :
$35
*
At a glance
- Drugs Darexaban (Primary) ; Digoxin
- Indications Arrhythmias; Thrombosis
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 08 Mar 2011 New trial record